Non-immune hemolytic anemia occurs in –
**Core Concept**
Non-immune hemolytic anemia (NIHA) is a condition characterized by the premature destruction of red blood cells (RBCs) not due to an immune-mediated mechanism. It is often caused by intrinsic or extrinsic factors that directly damage RBCs.
**Why the Correct Answer is Right**
In NIHA, the primary mechanism of RBC destruction involves oxidative stress, mechanical damage, or enzymatic degradation. Conditions such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, microangiopathic hemolytic anemia (MAHA), and paroxysmal nocturnal hemoglobinuria (PNH) are classic examples of NIHA. These conditions often lead to the activation of complement system on RBCs, making them more susceptible to phagocytosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because immune hemolytic anemia is a distinct entity characterized by the presence of autoantibodies or alloantibodies against RBC antigens. It is mediated by the immune system and is not directly related to intrinsic or extrinsic factors.
**Option B:** This option is incorrect because hemolytic uremic syndrome (HUS) is a form of MAHA, but it is primarily characterized by the presence of complement activation and thrombotic microangiopathy, rather than being a direct example of NIHA.
**Option C:** This option is incorrect because sickle cell anemia is a genetic disorder that affects hemoglobin production and leads to RBC deformity. While it does result in hemolysis, it is a distinct entity from NIHA and involves a different pathophysiological mechanism.
**Option D:** This option is incorrect because thalassemia is a genetic disorder that affects hemoglobin production and leads to RBC hypoplasia. While it does result in anemia, it is not typically classified as a form of NIHA.
**Clinical Pearl / High-Yield Fact**
When evaluating patients with hemolytic anemia, it is essential to distinguish between immune and non-immune causes, as the underlying pathophysiology and treatment approach differ significantly. A thorough history and laboratory evaluation, including direct antiglobulin test (DAT) and RBC morphology, are crucial in making this distinction.
**Correct Answer: A. Sickle cell anemia**